Infinity Laboratories Partners with Imperial Capital Group

by | Jul 5, 2018 | News

CASTLE ROCK, Colorado – Infinity Laboratories (“Infinity” or the “Company”), a full-service chemical and microbiological contract laboratory, is pleased to announce an investment by Imperial Capital Group Ltd. (“Imperial”), a Toronto-based private equity fund manager.

Founded in 1991, Infinity operates from a 25,000 square foot, state-of-the-art facility that provides critical testing services in the areas of chemical and microbiological sciences for FDA regulated manufacturers throughout North America.

“Imperial’s investment will offer far reaching resources to Infinity,” said Daniel Henderson, President and Chief Executive Officer of the Company. “It will enable the business to initiate significant capital projects across all of the Company’s business and laboratory units, furthering its mission to provide best-in-class analytical and microbiological testing, while remaining at the forefront of regulatory compliance and customer service.”

Christopher Harris, Principal at Imperial, commented, “We are pleased to partner with Daniel Henderson and are eager to continue building on the strong growth, continuous quality improvement, and dedication to customer service that have been the hallmarks of his leadership.”

“This is an exciting time to be at Infinity,” continued Mr. Henderson, “we plan to invest across all aspects of the Company in the coming months, but above all, we are excited to further invest in our people, the most important asset in our business.”

About Infinity Laboratories
Infinity Laboratories was founded in 1991 on the bedrock principles of excellence, integrity, and quality. Today, the Company is a national chemical and microbiological testing laboratory servicing the medical device and pharmaceutical industries.  For more information about Infinity Laboratories, please visit


About Imperial Capital Group
Imperial Capital Group is a Toronto-based private equity fund manager that focuses on buy-out opportunities in the U.S. and Canadian middle market. Currently drawing from its sixth fund with commitments of $500 million, Imperial invests in targeted niches within the healthcare, business, and consumer services industries.  For more information about Imperial, please visit


Infinity Laboratories
Daniel Henderson


Imperial Capital Group
Christopher Harris

Related Posts

BIOMEDevices Smart Event

BIOMEDevices Smart Event

UNCOVER the latest innovation #BIOMEDevicesSmartEvent We’re thrilled to announce that we’ll be participating at BIOMEDevice Silicon Valley! Come see us at Booth#320 BIOMEDevice Silicon Valley, formerly known as BIOMEDevice San Jose, returns this winter. As Silicon...

read more

Contact us today

Experience how Infinity Laboratories
goes Beyond Testing to meet your needs

Contact us